Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amir Englund

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|October 8, 2016
Traditional marijuana, high-potency cannabis and synthetic cannabinoids: increasing risk for psychosisRobin M Murray, Harriet Quigley, Diego Quattrone, et al.
Journal of Psychopharmacology (Oxford, England)|August 10, 2022
Can cannabis kill? Characteristics of deaths following cannabis use in England (1998-2020)Kirsten L Rock, Amir Englund, Stephen Morley, et al.
Journal of Psychopharmacology (Oxford, England)|November 19, 2015
The effect of five day dosing with THCV on THC-induced cognitive, psychological and physiological effects in healthy male human volunteers: A placebo-controlled, double-blind, crossover pilot trialAmir Englund, Zerrin Atakan, Aleksandra Kralj, et al.
Cannabis and Cannabinoid Research|May 17, 2021
Synthetic Cannabinoid-Related Deaths in England, 2012-2019Pruntha Yoganathan, Hugh Claridge, Lucy Chester, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 9, 2020
Adverse effects of cannabidiol: a systematic review and meta-analysis of randomized clinical trialsEdward Chesney, Dominic Oliver, Alastair Green, et al.
Journal of Psychopharmacology (Oxford, England)|November 1, 2017
The effects of cannabidiol on persecutory ideation and anxiety in a high trait paranoid groupHarneet Hundal, Rachel Lister, Nicole Evans, et al.
Schizophrenia Research|April 29, 2020
Real-world digital implementation of the Psychosis Polyrisk Score (PPS): A pilot feasibility studyDominic Oliver, Giulia Spada, Amir Englund, et al.
Systematic Reviews|January 25, 2025
The safety and efficacy of cannabinoids for the treatment of mental health and substance use disorders: protocol for a systematic review and meta-analysisJack Wilson, Andrew Langcake, Zachary Bryant, et al.
Frontiers in Psychiatry|August 8, 2024
Exploring the relationship between frequent cannabis use, belief updating under uncertainty and psychotic-like symptomsXinyi Liang, Maria-Mihaela Avram, Toni Gibbs-Dean, et al.
Experimental and Clinical Psychopharmacology|June 21, 2019
Changes in the composition of cannabis from 2000-2017 in Denmark: Analysis of confiscated samples of cannabis resinKristine Rømer Thomsen, Christian Lindholst, Birgitte Thylstrup, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|October 8, 2016
Traditional marijuana, high-potency cannabis and synthetic cannabinoids: increasing risk for psychosisRobin M Murray, Harriet Quigley, Diego Quattrone, et al.
Journal of Psychopharmacology (Oxford, England)|August 10, 2022
Can cannabis kill? Characteristics of deaths following cannabis use in England (1998-2020)Kirsten L Rock, Amir Englund, Stephen Morley, et al.
Journal of Psychopharmacology (Oxford, England)|November 19, 2015
The effect of five day dosing with THCV on THC-induced cognitive, psychological and physiological effects in healthy male human volunteers: A placebo-controlled, double-blind, crossover pilot trialAmir Englund, Zerrin Atakan, Aleksandra Kralj, et al.
Cannabis and Cannabinoid Research|May 17, 2021
Synthetic Cannabinoid-Related Deaths in England, 2012-2019Pruntha Yoganathan, Hugh Claridge, Lucy Chester, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 9, 2020
Adverse effects of cannabidiol: a systematic review and meta-analysis of randomized clinical trialsEdward Chesney, Dominic Oliver, Alastair Green, et al.
Journal of Psychopharmacology (Oxford, England)|November 1, 2017
The effects of cannabidiol on persecutory ideation and anxiety in a high trait paranoid groupHarneet Hundal, Rachel Lister, Nicole Evans, et al.
Schizophrenia Research|April 29, 2020
Real-world digital implementation of the Psychosis Polyrisk Score (PPS): A pilot feasibility studyDominic Oliver, Giulia Spada, Amir Englund, et al.
Systematic Reviews|January 25, 2025
The safety and efficacy of cannabinoids for the treatment of mental health and substance use disorders: protocol for a systematic review and meta-analysisJack Wilson, Andrew Langcake, Zachary Bryant, et al.
Frontiers in Psychiatry|August 8, 2024
Exploring the relationship between frequent cannabis use, belief updating under uncertainty and psychotic-like symptomsXinyi Liang, Maria-Mihaela Avram, Toni Gibbs-Dean, et al.
Experimental and Clinical Psychopharmacology|June 21, 2019
Changes in the composition of cannabis from 2000-2017 in Denmark: Analysis of confiscated samples of cannabis resinKristine Rømer Thomsen, Christian Lindholst, Birgitte Thylstrup, et al.
Pageof 4